Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc.
Your view on KBLB
Overview
What the company does, where it operates, and who runs it.
About Kraig Biocraft Laboratories, Inc.
- Industry
- Manufacturing - Textiles
- Sector
- Industrials
- CEO
- Kim Kraig Thompson
- Headquarters
- 2723 South State Street, Ann Arbor, MI, US
- Industry
- Manufacturing - Textiles
- Sector
- Industrials
- CEO
- Kim Kraig Thompson
- Headquarters
- 2723 South State Street, Ann Arbor, MI, US
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States.
The company's products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry.
Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation.
The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Kraig Biocraft Laboratories, Inc., and the rating behind it. KBLB last traded at $0.14; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Kraig Biocraft Laboratories, Inc.. Starting points for Kraig Biocraft Laboratories, Inc.: beta 1.40 — an Manufacturing - Textiles name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Kraig Biocraft Laboratories, Inc.. Kraig Biocraft Laboratories, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Kraig Biocraft Laboratories, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Kraig Biocraft Laboratories, Inc.. Kraig Biocraft Laboratories, Inc. has reported as a listed company since 2008. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Kraig Biocraft Laboratories, Inc. valued side by side against its closest peers. Kraig Biocraft Laboratories, Inc. is measured against Manufacturing - Textiles peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Kraig Biocraft Laboratories, Inc., and how their positions are changing. At a $151.4M market value, institutional positions materially move Kraig Biocraft Laboratories, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Kraig Biocraft Laboratories, Inc. executives and directors. Shares of Kraig Biocraft Laboratories, Inc. have traded between $0.07 and $0.15 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Kraig Biocraft Laboratories, Inc.. Kraig Biocraft Laboratories, Inc. is a $151.4M Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Kraig Biocraft Laboratories, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Kraig Biocraft Laboratories, Inc.. Coverage tracks Kraig Biocraft Laboratories, Inc. within Manufacturing - Textiles (Industrials). Press releases and market coverage, newest first.